Global Anti-Snoring & Sleep Apnea Devices Market Assessment & Forecast: 2016-2020

News provided by

Apr 27, 2016, 02:51 ET

LONDON, April 27, 2016 /PRNewswire/ -- According to the new report "Global Anti-Snoring & Sleep Apnea Devices Market Assessment & Forecast: 2016 - 2020" by SA-Business Research & Consulting Group, North America continues to lead the combined anti-snoring & sleep apnea market with a share of 37.5% in 2015. The region contributed to sales of US$ 2,775.1 million in 2015 and is forecast to grow to US$ 3,781.6 million by 2020 at a CAGR of 6.3% from 2016 to 2020. High awareness, diagnosis rate, obesity and availability of treatment options has ensured that the region leads in terms of innovation and adoption of devices.

The report focuses on this highly prospective market across six regions of North America, Europe, Asia-Pacific, Latin-America, Middle-East and Africa. The market varies from region to region based largely on two factors that are awareness of treatment for snoring and sleep apnea, and rate of diagnoses. The impact of diagnosis rate is significantly different in each region for snoring in particular, since it is considered a hindrance rather than a medical condition, thus often ignored by family members and snorers. United States's American Academy of Sleep Medicine has been known to accredit over 3000 sleep laboratories. As more and more individuals become aware of consequences of sleep deprivation, snoring and OSA/CSA the adoption rate for treatment devices has increased considerably over the past decade. Unlike most emerging regions, online shopping of healthcare products and in this instance - OTC cleared anti-snoring devices is anticipated to be high. This has led to a greater adoption.

The European market comprises the EU5 (United Kingdom, France, Germany, Spain, Italy) along with Scandinavia, Nordic region and countries in Eastern Europe as well. According to the European Sleep Research Society Insomnia and obstructive sleep apnea are the two most common sleep disorders (prevalence's 4-10%) in Europe and research now shows a much higher prevalence of co-morbidity (30-60%) than predicted previously. Although awareness of snoring and it's associated morbidities is considerably lower in Asia-Pacific regions such as India, China and South-East Asia, the market is expected to grow significantly in coming years due to improving medical facilities, growing awareness, and increasing number of companies entering this segment.

Some of the major companies mapped in the report according to operations in the above mentioned 6 regions include; ResMed, Philips Healthcare (Respironics), Somnetics, 3B Medical Inc, Hans Rudolph, GlaxoSmithKline (Breathe Right), SleepPro, Silent Partner, Fisher & Paykel, DeVilbiss Healthcare, Metamason, Walgreens, Provent Sleep Therapy, LLC, SnoreEze, Solarfarma, Rhinomed, HealthRight Products, LLC, SnoreTech, Tomed, Airway Management, Nora Inc, Hamilton Medical, Somnowell, PMI- ProBasics (Garden City Medical Inc), RespCare, Theravent Inc, Rematee, Puritan Bennett, Quies and Bestmed LLC. Devices across all categories of sleep apnea and anti-snoring have been mappd in this report and include appliances such as such as adhesive strips, clips, vents, mandibular advancement devices, expiratory PAP, tongue stabilizer or retainer, electronic wearable and remote monitored devices, chin straps, positional devices, positive airway pressure (CPAP, BiPAP & APAP), masks & tubing accessories, non-invasive ventilators, adaptive servo-ventilators and humidifiers.

Download the full report: https://www.reportbuyer.com/product/3795150/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com